Remove Marketing Remove Specialty Pharmacies Remove Vaccine
article thumbnail

Available for Preorder: The 2022 Economic Report on U.S. Pharmacies and Pharmacy Benefit Managers

Drug Channels

Pharmacies and Pharmacy Benefit Managers is a definitive, nonpartisan resource that includes the most current information about pharmacy dispensing channels, third-party payers, pharmacy benefit managers (PBMs), patients’ financial contributions, government regulations, and much more.

article thumbnail

16th Annual Life Sciences Trade and Channel Strategies

Drug Channels

Gain Critical Insight from Industry Trailblazers During a Time of Transformative Change – Speakers will include : Bill Roth, Founding Partner, Blue Fin Group Rob Osborne, Vice President Pharma Trade Relations, Express Scripts, Accredo, CuraScript SD Ray Tancredi, RPh, MBA, CSP, Divisional Vice President, Specialty Pharmacy Development & Brand Rx/Vaccine (..)

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

16th Annual Life Sciences Trade and Channel Strategies

Drug Channels

Stuart Parker, Senior Director, Trade Relations, Mayne Pharma And more!

article thumbnail

NOW AVAILABLE: The 2023–24 Economic Report on Pharmaceutical Wholesalers and Specialty Distributors

Drug Channels

The 2023–24 Economic Report on Pharmaceutical Wholesalers and Specialty Distributors —our 14th edition—remains the most comprehensive, fact-based tool for understanding and analyzing the large and growing U.S. Group purchasing organizations for small pharmacies (Section 2.2.5.) pharmaceutical distribution industry. and Section 6.4.3.

article thumbnail

FDA Flexibilities, Collaboration to Yield Millions of Bottles of Specialized Medical Infant Formula in Coming Months to Increase U.S. Supply

The Pharma Data

It is our goal to ensure that hospitals, specialty pharmacies, and retail store shelves will begin seeing adequate supplies again in the coming weeks.”. market and are made at facilities in Europe — amounts to more than 5 million full-size, 8-ounce bottles. “We continue to work closely with our U.S. as quickly as possible.

FDA 52